tm logo
Trademark Search
CELULARITY

View On IC.GC.CA

CELULARITY
ABANDONED SECTION 36

on 27 Nov 2024

Last Applicant/ Owned by

Celularity Inc.

170 Park AvenueFlorham Park NJ 07932

US

Serial Number

2219745 filed on 11th Aug 2022

CELULARITY

Trademark usage description

bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas Read More

Classification Information

Class [001]
Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research.

Classification kind code

11

Class [005]
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen.

Classification kind code

11

Class [040]
Custom manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; custom manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; custom production of cells for others; custom manufacturing of cells for others; advanced cell custom manufacturing for others; manufacturing process consulting.

Classification kind code

11

Class [042]
Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; technical writing and providing information via a website in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing.

Classification kind code

11

Mark Details

Serial Number

2219745

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 14
on 09th Sep 2024		Default Notice Sent
Submitted for opposition 22
on 21st Feb 2024		Search Recorded
Submitted for opposition 20
on 21st Feb 2024		Examiner's First Report
Submitted for opposition 223
on 21st Feb 2024		Total Provisional Refusal
Submitted for opposition 256
on 05th Sep 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 03rd Nov 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 02th Nov 2022		Created
Submitted for opposition 31
on 02th Nov 2022		Formalized
Submitted for opposition 30
on 11th Aug 2022		Filed
Submitted for opposition 228
on 11th Aug 2022		International Registration